Applicant, as named in the Orange Book
Dizal
Next listed expiry: Zegfrovy on 28 Jan 2039. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Zegfrovy NDA 219839 ยท 2 strengths sunvozertinib | 28 Jan 2039 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.